Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(3.84)
# 1,838
Out of 4,339 analysts
1211
Total ratings
51.9%
Success rate
3.5%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Sell | 11,500p | $13,960.00 | -17.62% | 182 | May 21, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 290.00 | $288.35 | +0.57% | 154 | May 20, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €725.00 → €750.00 | $699.70 | +7.19% | 32 | May 15, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,400 → kr 2,250 | $1,723.63 | +30.54% | 23 | May 11, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,900p | $1,925.00 | -1.30% | 162 | May 6, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | $118.44 | +13.98% | 129 | Apr 29, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 | $76.32 | +31.03% | 140 | Apr 28, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $140 | $92.25 | +51.76% | 32 | Mar 17, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | $331.20 | +2.66% | 139 | Mar 12, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Hold | $70 → $43 | $50.26 | -14.76% | 6 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 63.00 → CHF 70.00 | $64.78 | +8.06% | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.19 | - | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €285.00 → €295.00 | $243.60 | +21.10% | 25 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $806.46 | - | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.00 → €12.00 | $9.61 | +24.84% | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 → €14.00 | $11.84 | +18.24% | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | kr 285.00 | $439.00 | -35.08% | 17 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 | $23.84 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $44.15 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.00 | $4.22 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $47.03 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,064.74 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $3.42 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $8.02 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €124.00 | $161.40 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $52.57 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.91 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €44.00 | $51.30 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $128 → $58 | $27.64 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $51.50 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.76 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €80.00 | $37.82 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €61.83 → €78.00 | $128.35 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $150.80 | n/a | 4 | Dec 7, 2018 |
AstraZeneca PLC
May 21, 2026
Maintained: Sell
Price Target: 11,500p
Current: $13,960.00
Upside: -17.62%
Novo Nordisk A/S
May 20, 2026
Maintained: Hold
Price Target: kr 290.00
Current: $288.35
Upside: +0.57%
argenx SE
May 15, 2026
Maintained: Buy
Price Target: €725.00 → €750.00
Current: $699.70
Upside: +7.19%
Genmab A/S
May 11, 2026
Maintained: Buy
Price Target: kr 2,400 → kr 2,250
Current: $1,723.63
Upside: +30.54%
GSK plc
May 6, 2026
Reiterated: Hold
Price Target: 1,900p
Current: $1,925.00
Upside: -1.30%
Novartis AG
Apr 29, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: $118.44
Upside: +13.98%
Sanofi
Apr 28, 2026
Maintained: Buy
Price Target: €100.00
Current: $76.32
Upside: +31.03%
BioNTech SE
Mar 17, 2026
Maintained: Buy
Price Target: $140
Current: $92.25
Upside: +51.76%
Roche Holding AG
Mar 12, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: $331.20
Upside: +2.66%
Zealand Pharma A/S
Mar 12, 2026
Maintained: Hold
Price Target: $70 → $43
Current: $50.26
Upside: -14.76%
Feb 26, 2026
Downgraded: Hold
Price Target: CHF 63.00 → CHF 70.00
Current: $64.78
Upside: +8.06%
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.19
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: €285.00 → €295.00
Current: $243.60
Upside: +21.10%
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $806.46
Upside: -
Aug 5, 2025
Maintained: Hold
Price Target: €11.00 → €12.00
Current: $9.61
Upside: +24.84%
Jul 28, 2025
Maintained: Buy
Price Target: €12.00 → €14.00
Current: $11.84
Upside: +18.24%
Jul 8, 2025
Upgraded: Hold
Price Target: kr 285.00
Current: $439.00
Upside: -35.08%
Apr 28, 2025
Maintained: Hold
Price Target: €22.00
Current: $23.84
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $44.15
Upside: n/a
Nov 29, 2024
Maintained: Hold
Price Target: CHF 1.00
Current: $4.22
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $47.03
Upside: n/a
Jul 17, 2024
Maintained: Hold
Price Target: n/a
Current: $1,064.74
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $3.42
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $8.02
Upside: n/a
Aug 7, 2023
Maintained: Hold
Price Target: €95.00 → €124.00
Current: $161.40
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $52.57
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $26.91
Upside: n/a
Aug 9, 2022
Maintained: Hold
Price Target: €44.00
Current: $51.30
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $128 → $58
Current: $27.64
Upside: n/a
Apr 16, 2021
Maintained: Sell
Price Target: n/a
Current: $51.50
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $18.76
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: €80.00
Current: $37.82
Upside: n/a
Jan 15, 2019
Maintained: Sell
Price Target: €61.83 → €78.00
Current: $128.35
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $150.80
Upside: n/a